Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00231296 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of CryoCor™ Cryoablation for PAF
A NA study of Atrial Fibrillation, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 174
- Enrollment target
- 20
- Study locations
NCT00231296: Completed NA study of Atrial Fibrillation, sponsored by Boston Scientific Corporation.
NCT00231296 is a NA study of Atrial Fibrillation that has completed, run by Boston Scientific Corporation. The registered enrollment target is 174 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00231296, a NA study of Atrial Fibrillation, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
- 20
- Study locations
Study Summary
A multi-center, randomized, controlled study of cryoablation vs medical management for the treatment of PAF
Conditions Studied
Interventions
- DEVICE Cardiac CryoCor Cryoablation System
- DRUG Medical management
Study Locations (20)
California
- Regional Cardiology Associates - Sacramento
- UCSD Medical Center - San Diego
- UCSF Medical - San Francisco
Florida
- University of Florida - Gainesville
- University of South Florida - Tampa
Illinois
- University of Chicago Hospitals - Chicago
- Carle Heart Center - Urbana
Iowa
- Genesis Health - Davenport
- Iowa Heart Center - Des Moines
New York
- St. Luke's-Roosevelt Hospital Center - New York
- University of Rochester Medical Center - Rochester
Pennsylvania
- Penn State Heart and Vascular Institute - Hershey
- Drexel University - Philadelphia
Georgia
- Emory University - Atlanta
Kentucky
- Cardiology Associates of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2004-11 |
| Est. Completion | 2009-03 |
| Phase | NA |
What the finished NCT00231296 record still lists
NCT00231296 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Cardiac CryoCor Cryoablation System is the first listed.
NCT00231296 names 20 study sites across 13 states, led by California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT00231296 about?
NCT00231296 is a clinical study titled "Safety and Efficacy of CryoCor™ Cryoablation for PAF". A multi-center, randomized, controlled study of cryoablation vs medical management for the treatment of PAF
What is the current status of trial NCT00231296?
This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2004-11. Estimated completion is 2009-03.
What conditions does trial NCT00231296 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT00231296?
The interventions under investigation include: Cardiac CryoCor Cryoablation System (DEVICE), Medical management (DRUG).
Who is sponsoring clinical trial NCT00231296?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00231296 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00231296's enrollment target sits among peer trials
174 112th of 202 higher than 91 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- NCT04729114 · 174 participants · Phase 1
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- NCT04884035 · 174 participants · Phase 1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
- NCT05075980 · 174 participants · Phase 2
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia